Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland

European Journal of Cancer

Volumn 45, Issue 8, 2009, Pages 1450-1459

  Sharp, L ^a   Carsin, A E ^a   Cronin Fenton, D P ^b   O'Driscoll, D ^a   Comber, H ^a  

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Chemotherapy; Pancreatic cancer; Radiotherapy; Resection; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; FEMALE; HAZARD RATIO; HUMAN; HUMAN TISSUE; IRELAND; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PANCREAS CANCER; POPULATION; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RISK; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IRELAND; LOGISTIC MODELS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PATIENT SELECTION; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 65349184025     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.01.033     Document Type: Article

References (50)

1. Parkin D.M., Bray F., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Boyle P., and Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 16 (2005) 481-488
3. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
4. Faivre J., Forman D., Estève J., Obradovic M., Sant M., and EUROCARE Working Group. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. Eur J Cancer 34 (1998) 2184-2190
5. Michalski C.W., Weitz J., and Büchler M.W. Surgery insight: surgical management of pancreatic cancer. Nat Clin Pract Oncol 4 (2007) 526-535
6. Geer R.J., and Brennan M.F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165 (1993) 68-72
7. Nakeeb A., Lillemoe K.D., and Grosfeld J.L. Surgical techniques for pancreatic cancer. Minerva Chir 59 (2004) 151-163
8. Schmidt C.M., Powell E.S., Yiannoutsos C.T., et al. Pancreaticoduodenectomy. Arch Surg 139 (2004) 718-727
9. Wray CJ, Ahmad SA, Matthews JB, Lowy AM. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 2005;128:1626-41.
10. Cameron J.L., Riall T.S., Coleman J., and Belcher K.A. One thousand consecutive pancreaticoduodenectomies. Ann Surg 244 (2006) 10-15
11. Kalser M.H., and Ellenberg S.S. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120 (1985) 899-903
12. Bakkevold K.E., Arnesje B., Dahl O., and Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater-results of a controlled, prospective, randomised multicentre study. Eur J Cancer 29A (1993) 698-703
13. Oettle H., Post S., Neuhaus P., et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297 (2007) 267-277
14. Neuhaus P., Riess H., Post S., et al. CONKO-001: final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC). J Clin Oncol 26 suppl. (2008) LBA4504
15. Network National Comprehensive Cancer. NCCN clinical practice guidelines in oncology: pancreatic adenocarcinoma V.2.2006 (2006), NCCN, USA
16. National Institute for Clinical Excellence. Guidance on the use of gemcitabine for the treatment of pancreatic cancer. Technology appraisal guidance - no. 25. UK: NICE; 2001.
17. Pancreatic Section of the British Society of Gastroenterology, Pancreatic Society of Great Britain and Ireland, Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, Royal College of Pathologists, Special Interest Group for Gastro-Intestinal Radiology. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut 2005;54:v1-16.
18. Yip D., Karapetis C., Strickland A., Steer C.B., and Goldstein D. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev 3 (2006) CD002093
19. Cardenes H.R., Chiorean E.G., DeWitt J., Schmidt M., and Loehrer P. Locally advanced pancreatic cancer: current therapeutic approach. Oncologist 11 (2006) 612-623
20. Sultana A., Tudur Smith C., Cunningham D., et al. Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy. Brit J Cancer 96 (2007) 1183-1190
21. Riall T.S., Nealon W.H., Goodwin J.S., et al. Pancreatic cancer in the general population: improvements in survival over the last decade. J Gastrointest Surg 10 (2006) 1212-1224
22. Sener S.F., Fremgen A., Menck H.R., and Winchester D.P. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the national cancer database. J Am Coll Surg 189 (1999) 1-7
23. Krzyzanowska M.K., Weeks J.C., and Earle C.C. Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. J Clin Oncol 21 (2003) 3409-3414
24. Shaib Y., Davila J., Naumann C., and El-Serag H. The impact of curative intent surgery on the survival of pancreatic cancer patients: a US population-based study. Am J Gastroenterol 102 (2007) 1377-1382
25. National Cancer Registry. Cancer in Ireland, 1994 to 1998: incidence, mortality, treatment and survival. Report of the National Cancer Registry, Ireland. Cork, Ireland: NCR; 2001.
26. In: Young J.L., Roffers S.D., Ries L.A.G., Fritz A.G., and Hurlbut A.A. (Eds). SEER summary staging manual - 2000: codes and coding instructions (2001), SEER, Bethesda, MD
27. Kim H.J., Fay M.P., Feuer E.J., and Midthune D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19 (2000) 335-351
28. Joffe M.M., and Rosenbaum P.R. Invited commentary: propensity scores. Am J Epidemiol 150 (1999) 327-333
29. Shore S., Vimalachandran D., Raraty M.G.T., and Ghaneh P. Cancer in the elderly: pancreatic cancer. Surg Oncol 13 (2004) 201-210
30. Parks R.W., Bettschart V., Frame S., Stockton D.L., Brewster D.H., and Garden O.J. Benefits of specialisation in management of pancreatic cancer: results of a Scottish population-based study. Brit J Cancer 91 (2004) 459-465
31. Curado MP, Edwards B, Shin HR, et al. (editors). Cancer incidence in five continents, vol. IX. IARC Scientific Publications No. 160. Lyon: International Agency for Research on Cancer; 2007.
32. Janssen-Heijnen M.L., Houterman S., Lemmens V.E., Louwman M.W., Maas H.A., and Coebergh J.W. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 55 (2005) 231-240
33. Conlon K.C., Klimstra D.S., and Brennan M.F. Long-term survival after curative resection of pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 223 (1996) 273-279
34. Carpelan-Holmström M., Nordling S., Pukkala E., et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish cancer registry. Gut 54 (2005) 385-387
35. Lim J.E., Chien M.W., and Earle C.C. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237 (2003) 74-85
36. van Oost F.J., Luiten E.J.T., van de Poll-Franse L.V., Coebergh J.W.W., and van den Eijnden-van Raaij A.J.M. Outcome of surgical treatment of pancreatic, peri-ampullary and ampullary cancer diagnosed in the south of the Netherlands: a cancer registry based study. Eur J Surg Oncol 32 (2006) 548-552
37. Linder S., Boström L., and Nilsson B. Pancreatic cancer in Sweden 1980-2000: a population-based study of hospitalized patients concerning time trends in curative surgery and other interventional therapies. J Gastrointest Surg 10 (2006) 672-678
38. Cress R.D., Yin D., Clarke L., Bold R., and Holly E.A. Survival among patients with adenocarcinoma of the pancreas: population-based study (United States). Cancer Causes Contr 17 (2006) 403-409
39. Eloubeidi M.A., Desmond R.A., Wilcox C.M., et al. Prognostic factors for survival in pancreatic cancer: a population-based study. Am J Surg 192 (2006) 322-329
40. Bilimoria K.Y., Bentrem D.J., Ko C.Y., Stewart A.K., Winchester D.P., and Talamonti M.S. National failure to operate on early stage pancreatic cancer. Ann Surg 246 (2007) 173-180
41. Halm E.A., Lee C., and Chassin M.R. Is volume related to outcome in health care? A systematic review and methodological critique of the literature. Ann Intern Med 137 (2002) 511-520
42. Sultana A., Tudur Smith C., Cunningham D., Starling N., Neoptolemos J.P., and Ghaneh P. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses. Brit J Cancer 99 (2008) 6-13
43. Bramhall S.R., Allum W.H., Jones A.G., Allwood A., Cummins C., and Neoptolemos J.P. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Brit J Surg 82 (1995) 111-115
44. Bachmann M.O., Alderson D., Peters T.J., et al. Influence of specialization on the management and outcome of patients with pancreatic cancer. Brit J Surg 90 (2003) 171-177
45. Maréchal R., Demols A., Gay F., et al. Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer. Pancreas 36 (2008) e16-e21
46. Petrowsky H., and Clavien P.A. Should we deny surgery for malignant hepto-pancreatico-biliary tumors to elderly patients?. World J Surg 29 (2005) 1093-1100
47. Casadei R., Zanini N., Morselli-Labate A.M., et al. Prognostic factors in periampullary and pancreatic tumor resection on elderly patients. World J Surg 30 (2006) 1992-2001
48. Cronin-Fenton D.P., Sharp L., Deady S., and Comber H. Treatment and survival for non-Hodgkin's lymphoma: influence of histological subtype, age, and other factors in a population-based study. Eur J Cancer 42 (2006) 2786-2793
49. Cronin-Fenton D.P., Sharp L., Carsin A.E., and Comber H. Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: a population-based study. Eur J Cancer 43 (2007) 565-575
50. Carsin AE, Sharp L, Cronin-Fenton DP, Ó Céilleachair A, Comber H. Inequity in colorectal cancer treatment and outcomes: a population-based study. Brit J Cancer 2008;99:266-74.